Mar 31, 2022

Arcturus Therapeutics Q1 2022 Earnings Report

Total Revenue
$5.24M
Previous year: $2.13M
+146.5%
EPS
-$1.94
Previous year: -$2.15
-9.8%
Gross Profit
$5.24M
Cash and Equivalents
$320M
Free Cash Flow
-$51.2M
Total Assets
$342M

Arcturus Therapeutics

Arcturus Therapeutics